Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
31.10. | Johnson & Johnson MedTech CIO says 'see you later' | ||
31.10. | Neurovascular intervention tech developer Q'Apel names former Stryker VP as CCO | ||
31.10. | FDA clears Exactech porous 3D tibial implant for knee replacement | ||
31.10. | SynCardia picks up patent for total artificial heart | ||
31.10. | Smith+Nephew stock sinks as surgical business faces China headwinds | ||
31.10. | FDA clears second set of changes to iRhythm Zio AT to resolve warning letter | ||
30.10. | Solventum to spend $209M on new Minnesota HQ | ||
30.10. | Novocure picks successor for CFO taking over corner office | ||
30.10. | Johnson & Johnson completes pilot enrollment in Omnypulse trial | ||
30.10. | RFK Jr. says he'll control FDA and Health and Human Services if Trump wins | ||
30.10. | Boston Scientific Acurate neo2 TAVR misses primary endpoint in IDE trial | ||
30.10. | Paragonix Technologies announces first-in-human use of PancreasPak organ preservation system | ||
30.10. | Cognito Therapeutics' Alzheimer's treatment reduces dependence score by 56% | ||
30.10. | Edwards study shows superiority of Evoque tricuspid valve replacement | ||
30.10. | GE HealthCare posts mixed Q3 as conditions in China impact sales guidance | ||
30.10. | FDA approves Abbott CGMs for use during medical imaging | ||
30.10. | AtriCure plans a surgical pulsed field ablation play | ||
30.10. | BD launches intraosseous vascular access system | ||
30.10. | Zimmer Biomet posts Q3 beat but narrows full-year guidance | ||
30.10. | Stryker posts Street-beating Q3, raises low end of guidance | ||
29.10. | Insulet fully launches Omnipod 5 app for iPhone in U.S. | ||
29.10. | Inari Medical's FlowTriever meets primary endpoint in pulmonary embolism trial | ||
29.10. | Elixir Medical has positive data for drug-eluting bioadaptive implant | ||
29.10. | Masimo sues founder Joe Kiani, RTW Investments over alleged voting manipulation scheme | ||
29.10. | Exactech begins court-supervised restructuring, prepares for asset sale to address legal liabilities |